| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―14 |
Arterial and Venous Thromboembolism in Hospitalized COVID-19 Patients: A National Multicenter Cohort Study |
Rushad Patell, Phuong H. Nguyen, Dana Angelini, Carl Wilson, Sunita Ghosh, Stacy Ellsworth, et al. (+15) Paul Lewis, James C Lee, Edith Nutescu, Alpesh N. Amin, Daniel M. Witt, Marisol Betensky, Neil Goldenberg, Peter Kouides, Doaa Attia, Lyla Mourany, Leslie Lake, Rachel P. Rosovsky, Wei He, Alok A. Khorana, Scott Kaatz |
| 2 |
[GO] |
2026―Feb―16 |
Enduring coagulopathy and endothelial dysfunction in post-acute COVID-19 syndrome |
Yucan Li, Tichao Shan, Zhengqi Jiang, Fengjiao Han, Ji Ma, Heyu Ni, et al. (+2) Jun Peng, Miao Xu |
| 3 |
[GO] |
2026―Jan―05 |
Tryptophan metabolism reprogramming potentially contributes to prothrombotic milieu in mice and humans with SARS-CoV-2 |
Saravanan Subramaniam, Marc Arthur Napoleon, Saran Lotfollahzadeh, Mohamed Hassan Kamal, Helena Kurniawan, Christina Francis, et al. (+12) Murad Elsadawi, David Jasen Wu Wong, Devin Kenney, Florian Douam, Markus Bosmann, Stephen Whelan, Howard Cabral, Eric J Burks, Grace Zhao, Vijaya B. Kolachalama, Katya Ravid, Vipul C. Chitalia |
| 4 |
[GO] |
2026―Jan―05 |
Exploring Blood Transcriptional Signatures for Thrombosis Diagnosis in Critically Ill COVID-19 Patients |
Cosimo Cristella, Matthijs Raadsen, Hugo D.G. van Willigen, Karen de Haan, Sarah van Leeuwen, Mohammad R. Toliat, et al. (+12) Niculina Dalibor, Daniel G. Aynekulu Mersha, Johannes P.C. van den Akker, Henrik Endeman, Pieter L.A. Fraaij, Diederik A.M.P.J. Gommers, Eric C.M. van Gorp, Nicole P. Juffermans, Brendon P. Scicluna, Jorrit J. Hofstra, Marion P.G. Koopmans, Menno D. de Jong |
| 5 |
[GO] |
2025―Apr―29 |
Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes |
Alicia S. Eustes, Meena Kumari Palani Kumar, Julie A. Peterson, Alan E. Mast, Steven R. Lentz, Sanjana Dayal |
| 6 |
[GO] |
2025―Jan―14 |
`Association of High γ' Fibrinogen Levels with Adverse Events in COVID-19 Patients |
Queen Revollido, Lydia Buzzard, David X. Lee, Matthew Strnad, Scott Mcloud, Akram Khan, et al. (+2) William B. Messer, David H. Farrell |
| 7 |
[GO] |
2024―Nov―26 |
Immunothrombosis and plasma fibrinolytic function for pediatric COVID-19: A secondary analysis from the COVAC-TP trial |
Anthony A. Sochet, Austin R. Sellers, Marisol Betensky, John M. Morrison, Dina Ashour, Jamie L. Fierstein, et al. (+4) Ernest K. Amankwah, Steven Bruzek, Vera Ignjatovic, Neil A. Goldenberg |
| 8 |
[GO] |
2024―Feb―24 |
Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID pandemic |
Divya Karsanji, James A. King, Jenny Godley, Deborah M. Siegal, Teresa M. Chan, Grégoire Le Gal, et al. (+10) Marc Carrier, Susan R. Kahn, Tobias Tritschler, Nicole J. Langlois, Chad Saunders, Ramy Saleh, Alexandra Garven, Caleb MacGillivray, Marc A. Rodger, Leslie Skeith |
|
